J-Alex Trial_ Should Alecensa Replace Xalkori as First-Line ALK Therapy_ [720p]

J-Alex Trial_ Should Alecensa Replace Xalkori as First-Line ALK Therapy_ [720p]

User Photo
cancergrace

2 years
149 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the J-Alex trial and whether Alecensa should replace Xalkori as First-Line ALK Therapy.
Up Next Autoplay
User Photo